ARQT icon

Arcutis Biotherapeutics

224 hedge funds and large institutions have $1.78B invested in Arcutis Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 87 increasing their positions, 65 reducing their positions, and 45 closing their positions.

Holders
224
Holders Change
-15
Holders Change %
-6.28%
% of All Funds
3.01%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
35
Increased
87
Reduced
65
Closed
45
Calls
$8.93M
Puts
$1.25M
Net Calls
+$7.67M
Net Calls Change
-$1.15M
Name Market Value Shares Shares
Change
Shares
Change %
QC
251
Quadrature Capital
United Kingdom
-11,026 Closed
BBA
252
Baader Bank Aktiengesellschaft
Germany
-10,000 Closed
AI
253
Allostery Investments
Connecticut
-7,500 Closed
NL
254
NKCFO LLC
Illinois
-7,000 Closed
PHK
255
Point72 Hong Kong
Hong Kong
-3,280 Closed
CCM
256
Coldstream Capital Management
Washington
-2,169 Closed
PD
257
Point72 (DIFC)
United Arab Emirates
-2,149 Closed
QCG
258
Quadrant Capital Group
Ohio
-1,550 Closed
CIAM
259
Caitong International Asset Management
Hong Kong
-1,032 Closed
AF
260
Advisornet Financial
Minnesota
-577 Closed
SW
261
SVB Wealth
Massachusetts
-262 Closed
ACM
262
Aster Capital Management
United Arab Emirates
-235 Closed
MG
263
Mather Group
Illinois
-190 Closed
Amundi
264
Amundi
France
-66 Closed
CA
265
CoreCap Advisors
Michigan
-38 Closed
SC
266
Stephens Consulting
Michigan
-25 Closed
PA
267
Parallel Advisors
California
-14 Closed
TWD
268
True Wealth Design
Ohio
-9 Closed
C
269
Covestor
United Kingdom
$0 9 -1 -10%
CCM
270
Catalio Capital Management
New York
Simplex Trading
271
Simplex Trading
Illinois
Group One Trading
272
Group One Trading
Illinois